Adina Grunn

Columbia University Irving Medical Center

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index18

i10-index19

Publications86

Citations5,253

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 31

Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
2025-12-11
Systematic elucidation and pharmacologic targeting of non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumorPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-10-14
Table S4 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S5 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S1 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S1 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Key Resources Table from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S6 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S7 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S8 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16
Table S7 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignanciesPreprint
2024-09-16

Open author page on OpenAlex →